Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION FOR PREVENTING AND TREATING MUSCULAR DISEASE
Document Type and Number:
WIPO Patent Application WO/2019/208968
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition comprising dimenhydrinate, harmol, and/or calcium pantothenate for preventing or treating a muscular disease, wherein dimenhydrinate, harmol, and/or calcium pantothenate each independently have an effect of promoting the proliferation and differentiation of myoblasts, and in particular, when combined, the effect of promoting the proliferation and differentiation of myoblasts can be synergistically increased. Accordingly, dimenhydrinate, harmol, and/or calcium pantothenate may be beneficially used, either independently or in various combinations, for preventing or treating a muscular disease, in particular, sarcopenia.

Inventors:
KIM, Yi-Rang (#308-803, 159Doum 3-ro, Sejong, 30064, KR)
CHOI, Jin-Woo (#101-302, 102 Sadang-ro 2ga-gil,Dongjak-gu, Seoul, 07028, KR)
Application Number:
KR2019/004631
Publication Date:
October 31, 2019
Filing Date:
April 17, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ONCOCROSS CO.,LTD. (15F 11, Saechang-roMapo-gu, Seoul, 04168, KR)
International Classes:
A61K31/522; A23L33/10; A61K31/197; A61K31/437; A61P21/00
Domestic Patent References:
WO2017218905A12017-12-21
WO2005009370A22005-02-03
WO2007088123A22007-08-09
WO2006081997A22006-08-10
Foreign References:
US20060166978A12006-07-27
US9572810B22017-02-21
US5554647A1996-09-10
Other References:
SARCOPENIA THERAPEUTICS-PIPELINE ASSESSMENT AND MARKET FORECASTS TO 2018, 17 November 2011 (2011-11-17)
"Goodman and Gilman's The Pharmacological Basis of Therapeutics", 2001, PERGAMON PRESS
"Remington's Pharmaceutical Sciences", 1990, MACK PUBLISHING COMPANY
"Merck Index", MERCK & CO. INC.
Attorney, Agent or Firm:
WIE, Byoung-Gap (Dae-young Bldg, 7F 7, Teheran-ro 33-gil,,Gangnam-gu, Seoul, 06141, KR)
Download PDF: